Penn’s Siloxane-Enhanced Nanoparticles Chart a New Path in Precision mRNA Medicine News / October 1, 2024 Penn Engineers have discovered a novel means of directing lipid nanoparticles (LNPs), the revolutionary molecules that delivered the COVID-19 vaccines, to target specific tissues, presaging a new era in personalized medicine and gene therapy. While past research — including at Penn Engineering — has screened “libraries” of LNPs to find... Read More
